H19 and hepatocellular carcinoma: There are several cancers with abnormal expression of H19: breast cancers, pancreatic cancers (Ma et al., 2014), choriocarcinomas (Arima et al., 1997), hepatocellular carcinomas (Ye et al., 2019), ovarian cancers (Tanos et al., 1999), and so on (Ariel et al., 2000a).